Table I.
N. of patients | 99 |
Sex (male/female) | 48/51 |
Median age, years | 46 (range 11–67) |
Diagnosis | |
Acute myeloid/lymphocytic leukaemia | 38/15 |
Chronic lymphocytic leukaemia | 8 |
CML/MDS | 6/2 |
NHL/HL | 12/7 |
Multiple myeloma | 10 |
Aplasia | 1 |
Disease status (early/advanced) | 66/33 |
Donor type (matched/mismatched) | 84/15 |
Donor median age, years | 41 (range 15–65) |
Donor sex (male/female) | 58/41 |
ABO compatibility (id/minor/major) | 67/13/19 |
Cell source (BM/PB) | 23/76 |
Conditioning (myeloablative/RIC) | 48/51 |
Legend:
CML: chronic myeloid leukaemia; MDS: myelodysplastic syndrome; NHL: non-Hodgkin’s lymphoma; HL: Hodgkin’s lymphoma; BM: bone marrow; PB: peripheral blood; RIC: reduced intensity conditioning).